The effects of different dietary fatty acids on chylomicron synthesis and secretion by Caco-2 cells and humans

by Bateman, Paul Alexander
Published 2004

A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome.

by David R Strayer, William A Carter, Bruce C Stouch, Staci R Stevens, Lucinda Bateman, Paul J Cimoch, Charles W Lapp, Daniel L Peterson, Chronic Fatigue Syndrome AMP-516 Study Group, William M Mitchell
Published 2012-01-01